Debt-to-equity of Nuvation Bio Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nuvation Bio Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Nuvation Bio Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 64%, a 412% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nuvation Bio Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 64% +52% +412% 31 Dec 2025
Q3 2025 44% +36% +419% 30 Sep 2025
Q2 2025 28% +22% +394% 30 Jun 2025
Q1 2025 17% +14% +483% 31 Mar 2025
Q4 2024 13% +9.8% +354% 31 Dec 2024
Q3 2024 8.5% +5.8% +212% 30 Sep 2024
Q2 2024 5.7% +3% +115% 30 Jun 2024
Q1 2024 2.9% -0.01% -0.32% 31 Mar 2024
Q4 2023 2.8% -0.55% -17% 31 Dec 2023
Q3 2023 2.7% -0.93% -25% 30 Sep 2023
Q2 2023 2.6% -1.2% -32% 30 Jun 2023
Q1 2023 3% -0.76% -20% 31 Mar 2023
Q4 2022 3.3% -0.22% -6.2% 31 Dec 2022
Q3 2022 3.7% +0.32% +9.6% 30 Sep 2022
Q2 2022 3.9% +0.78% +25% 30 Jun 2022
Q1 2022 3.7% 31 Mar 2022
Q4 2021 3.5% 31 Dec 2021
Q3 2021 3.3% 30 Sep 2021
Q2 2021 3.1% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.